• Most Popular
  • Most Shared

SuperGen signs cancer-drug deal with Glaxo, shares rise

Mon Oct 26, 2009 9:29am EDT

Stocks

   

*SuperGen to get $5 mln in upfront payment

Stocks  |  Global Markets  |  Healthcare

*Potential milestones payable to SuperGen may exceed $375 mln

*SuperGen shares up as much as 28 pct in pre-mkt trade

Oct 26 (Reuters) - Cancer drug developer SuperGen Inc (SUPG.O) said it entered into a multi-year collaboration with GlaxoSmithKline Plc (GSK.L) to discover and develop cancer therapeutics for an upfront payment of $5 million.

The upfront payment includes a $3 million common stock investment, SuperGen said and added that total potential development and commercialization milestones payable to it could exceed $375 million.

Shares of SuperGen soared 28 percent to $3.05 in pre-market trade. They had closed at $2.38 Friday on Nasdaq.

According to the deal, SuperGen will progress drug candidates through to early clinical development, and Glaxo will have the right to exercise an option to develop them further and market the drugs globally.

The companies would develop cancer therapeutics based on epigenetic targets, which refer to the regulation of genes with mechanisms other than changes to the underlying DNA sequence.

Epigenetic processes are widely believed to play a central role in the development and progression of almost all cancers, the company said. (Reporting by Esha Dey in Bangalore; Editing by Himani Sarkar)

Stocks
Global Markets
Healthcare


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets